Jarred Younger, PhD - Calming microglia: a future method for treating multiple sclerosis (2016 Conference) (LDN, low dose naltrexone)
In this presentation Dr Younger speaks about the off label use of Low Dose Naltrexone (LDN) and calming microglia, which is a scientific approach used to treat his patients.
Dr Younger opens by explaining the typical cycle of an MS patient, progressing from the first episode onto Relapsing-remitting MS (RRMS) and Secondary Porgressive MS. The pathophysiology of MS is also demonstrated through Dr younger’s images and diagrams.
The importance of clinical trials are also stressed by Dr Younger, providing an depth table of statistics on the status of LDN and MS clinical trials. In a 2015 study, 60% of LDN patients reported improved disease severity and fatigue.
This is a summary of Dr Jarred Younger’s presentation. Please listen to the rest of Dr Younger’s presentation by clicking on the video above.
Past Conferences can be found https://ldnresearchtrust.org/ldn-conferences